References

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

10.1172/jci200318127 · 2003 · External reference

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

10.1038/35008121 · 2000 · External reference

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

10.1038/nm834 · 2003 · External reference

The pathobiology of diabetic complications: a unifying mechanism

10.2337/diabetes.54.6.1615 · 2005 · External reference

Diabetes-induced extracellular matrix protein expression is mediated by transcription co-activator p300

10.2337/db06-0519 · 2006 · External reference

Transcriptional co-activator p300 regulates glucose induced gene expression in the endothelial cells

10.1152/ajpendo.00432.2009 · 2010 · External reference

Oncofetal fibronectin in diabetic retinopathy

10.1167/iovs.03-0540 · 2004 · External reference

EDB fibronectin and angiogenesis - a novel mechanistic pathway

10.1007/s10456-005-9017-6 · 2005 · External reference

Fibronectin at a glance

10.1242/jcs.00059 · 2002 · External reference

Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro

10.1002/dmrr.860 · 2008 · External reference

Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat

10.1016/j.phrs.2008.09.012 · 2008 · External reference

Vitamin B1 analogue benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1 mediated survival pathway

10.1161/circheartfailure.109.903450 · 2010 · External reference

Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications

10.1152/ajpendo.00540.2002 · 2003 · External reference

Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine

10.1002/dmrr.996 · 2009 · External reference

Endothelin receptor blockade prevents augmented extracellular matrix protein component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose fed rats

10.2337/diabetes.49.4.662 · 2000 · External reference

Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors

10.1006/jmcc.2000.1197 · 2000 · External reference

Antioxidant activity of chito-oligosaccharides on pancreatic islet cells in streptozotocin-induced diabetes in rats

10.3748/wjg.15.1339 · 2009 · External reference

PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes

10.1002/dmrr.842 · 2008 · External reference

PARP mediates structural alterations in diabetic cardiomyopathy

10.1016/j.yjmcc.2008.06.009 · 2008 · External reference

A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-β activation in the kidneys of rats used as a model of diabetes

10.1007/s00125-008-1088-7 · 2008 · External reference

Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model

10.1016/j.bcp.2009.11.018 · 2010 · External reference

The multifaceted therapeutic potential of benfotiamine

10.1016/j.phrs.2010.02.008 · 2010 · External reference

The potential role of thiamine (vitamin B1) in diabetic complications

10.2174/157339905774574383 · 2005 · External reference

Advances in biochemical mechanisms of diabetic retinopathy

2007 · External reference

Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study

10.1055/s-2008-1065351 · 2008 · External reference

Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat

10.1007/s11010-008-9917-z · 2009 · External reference

Biological role of p300 in cardiac myocytes

10.1023/a:1024132217870 · 2003 · External reference

CBP/p300 in cell growth, transformation, and development

10.1101/gad.14.13.1553 · 2000 · External reference

Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation

10.1007/s00109-003-0469-0 · 2003 · External reference